Health
Synthetic Nanobodies Identified That Neutralize SARS-CoV-2 – Anti Aging News
ACE2 has become the key target of COVID-19 therapeutics investigating interrupting the interaction between the spike protein on the SARS-CoV-2 virus and its receptor…
ACE2 has become the key target of COVID-19 therapeutics investigating interrupting the interaction between the spike protein on the SARS-CoV-2 virus and its receptor on host cells; recent work published in Nature Communications suggests that a synthetic nanobody, sybodies, has been found that can neutralize SARS-CoV-2 constituting a potential treatment. The group of researchers are reporting the rapid isolation and characterization of nanobodies from a synthetic library called sybodies that target…
-
Business23 hours agoWhere will Berkshire Hathaway be in 1 year?
-
Noosa News17 hours agoTwo trapped and fighting for life after major three-vehicle crash in Brisbane
-
Business18 hours agoUp 105% in a year, are Pro Medicus shares still a good buy today?
-
Noosa News14 hours agoQueensland man sentenced to four years imprisonment after string of terror offences